Gmryl-MP1 Tablet ER
Marketer
Gms Biomax Medicare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gmryl-MP1 Tablet ER
Diabetol-XR is a dual-action medication designed to manage blood glucose. In conjunction with diet and exercise, it enhances glycemic control in adults with type 2 diabetes. Its mechanism involves improved insulin utilization, leading to reduced blood sugar. Diabetol-XR should be administered precisely as prescribed, taken with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case the missed dose should be omitted. Never double the dose; overdose can result in hypoglycemia. Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, patients with kidney, liver, or heart conditions should consult their physician. Pregnant or lactating women should seek medical advice before use. Renal function will be assessed prior to treatment initiation. Excessive alcohol should be avoided as it may heighten the risk of adverse reactions.
Uses of Gmryl-MP1 Tablet ER
Managing Type 2 diabetes
Major Benefits of Gmryl-MP1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gmryl-MP1 Extended-Release Tablet should be administered with a meal.
Common Side effects of Gmryl-MP1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gmryl-MP1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Gmryl-MP1 Extended-Release tablets should be taken with a meal.
How Gmryl-MP1 Tablet ER works:
Gmryl-MP1 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Gmryl-MP1 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gmryl-MP1 Tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gmryl-MP1 tablets are likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Exercise caution when administering Gmryl-MP1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Gmryl-MP1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gmryl-MP1 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Gmryl-MP1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Gmryl-MP1 Tablet ER :
Should you forget a Gmryl-MP1 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gmryl-MP1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently